• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维连接蛋白-2 在肥厚型心肌病中的研究

An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy.

机构信息

Aswan Heart Center, Aswan 200, Egypt.

Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt.

出版信息

Int J Mol Sci. 2020 Sep 29;21(19):7176. doi: 10.3390/ijms21197176.

DOI:10.3390/ijms21197176
PMID:33003281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7583916/
Abstract

Hypertrophic cardiomyopathy (HCM) is the most common inherited heart muscle disease, with a prevalence of at least 1 in 500 in the general population. The disease is pleiotropic and is characterized by an increased stiffness of the myocardium, partly due to changes in the extracellular matrix (ECM), with elevated levels of interstitial fibrosis. Myocardial fibrosis is linked to impaired diastolic function and possibly phenotypic heterogeneity of HCM. The ECM consists of a very large number of proteins, which actively interact with each other as well as with myocardial cells. The role of other multiple components of the ECM in HCM has not been defined. Fibulin-2 is a glycoprotein component of the ECM, which plays an important role during embryogenesis of the heart; however, its role in adult myocardium has not been adequately studied. We here describe, for the first time, abnormal expression of fibulin-2 in the myocardium in patients with HCM as compared to normal controls. This abnormal expression was localized in the cytoplasm of myocardial cells and in the interstitial fibroblasts. In addition, fibulin-2 levels, measured by ELISA, were significantly elevated in the serum of patients with HCM as compared to normal controls.

摘要

肥厚型心肌病(HCM)是最常见的遗传性心肌疾病,在普通人群中的患病率至少为每 500 人中有 1 人。该疾病具有多效性,其特征是心肌僵硬度增加,部分原因是细胞外基质(ECM)的变化,间质纤维化程度升高。心肌纤维化与舒张功能障碍有关,并且可能与 HCM 的表型异质性有关。ECM 由大量蛋白质组成,这些蛋白质彼此之间以及与心肌细胞之间都有积极的相互作用。ECM 的其他多个成分在 HCM 中的作用尚未确定。纤连蛋白-2是 ECM 的糖蛋白成分,在心脏胚胎发生过程中发挥着重要作用;然而,其在成年心肌中的作用尚未得到充分研究。我们首次描述了 HCM 患者心肌中纤连蛋白-2的异常表达与正常对照组相比。这种异常表达定位于心肌细胞的细胞质和间质成纤维细胞中。此外,通过 ELISA 测量的纤连蛋白-2水平在 HCM 患者的血清中明显高于正常对照组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/4605e0e98e73/ijms-21-07176-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/0348223705bc/ijms-21-07176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/a9e68521e5ec/ijms-21-07176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/8a668e9415d9/ijms-21-07176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/4605e0e98e73/ijms-21-07176-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/0348223705bc/ijms-21-07176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/a9e68521e5ec/ijms-21-07176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/8a668e9415d9/ijms-21-07176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d2/7583916/4605e0e98e73/ijms-21-07176-g004.jpg

相似文献

1
An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy.纤维连接蛋白-2 在肥厚型心肌病中的研究
Int J Mol Sci. 2020 Sep 29;21(19):7176. doi: 10.3390/ijms21197176.
2
CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.CCN2 在严重肥厚型心肌病和心力衰竭的细胞外基质基因表达中发挥关键作用。
J Mol Cell Cardiol. 2013 Sep;62:164-78. doi: 10.1016/j.yjmcc.2013.05.019. Epub 2013 Jun 10.
3
An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.新型药理学疗法在肥厚型心肌病中的研究进展。
Med Chem. 2011 Jul;7(4):275-85. doi: 10.2174/157340611796150941.
4
T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.T1 Mapping在肥厚型表型鉴别中的应用:高血压性心脏病和肥厚型心肌病:国际T1多中心心血管磁共振研究结果
Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.115.003285.
5
Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.肥厚型心肌病肌节突变携带者伴或不伴左心室肥厚时心肌微观结构的超声评估
Circ Heart Fail. 2016 Sep;9(9). doi: 10.1161/CIRCHEARTFAILURE.116.003026.
6
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts.肥厚型心肌病中的心肌纤维化:成纤维细胞的视角。
Int J Mol Sci. 2023 Oct 2;24(19):14845. doi: 10.3390/ijms241914845.
7
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.醛固酮通过新型信号蛋白,是肥厚型心肌病遗传缺陷与心脏表型之间的基本分子桥梁。
Circulation. 2004 Mar 16;109(10):1284-91. doi: 10.1161/01.CIR.0000121426.43044.2B. Epub 2004 Mar 1.
8
Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.RETN-420C>G 多态性与肥厚型心肌病患者心肌纤维化的关系。
J Intern Med. 2015 Jul;278(1):50-8. doi: 10.1111/joim.12334. Epub 2015 Jan 5.
9
Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) study.Scleraxis 作为肥厚型心肌病心肌纤维化的预后标志物(SPARC)研究。
Can J Physiol Pharmacol. 2020 Jul;98(7):459-465. doi: 10.1139/cjpp-2019-0636. Epub 2020 Feb 6.
10
Imaging cardiac morphology in hypertrophic cardiomyopathy: recent advances.肥厚型心肌病的心脏形态成像:最新进展
Curr Opin Cardiol. 2015 Sep;30(5):461-7. doi: 10.1097/HCO.0000000000000209.

引用本文的文献

1
Matrisome remodeling in the myocardium of hypertrophic cardiomyopathy; novel targets for molecular diagnostics.肥厚型心肌病心肌中的基质重塑;分子诊断的新靶点。
Front Cell Dev Biol. 2025 Aug 6;13:1641584. doi: 10.3389/fcell.2025.1641584. eCollection 2025.
2
Fibulin 1 and 2 Levels in Patients with Heart Failure: Comparison of Different Heart Failure Stages and Exploring the Temporal Changes During Acute Exacerbation.心力衰竭患者中纤连蛋白1和2的水平:不同心力衰竭阶段的比较以及急性加重期的时间变化探索
Rev Cardiovasc Med. 2025 Feb 21;26(2):26364. doi: 10.31083/RCM26364. eCollection 2025 Feb.
3
Structural and Functional Characterization of the Aorta in Hypertrophic Obstructive Cardiomyopathy.

本文引用的文献

1
Fibulin-2 is required for basement membrane integrity of mammary epithelium.纤连蛋白-2 对于乳腺上皮基底膜的完整性是必需的。
Sci Rep. 2018 Sep 20;8(1):14139. doi: 10.1038/s41598-018-32507-x.
2
Extracellular Interactions between Fibulins and Transforming Growth Factor (TGF)-β in Physiological and Pathological Conditions.纤连蛋白与转化生长因子-β在生理和病理条件下的细胞外相互作用。
Int J Mol Sci. 2018 Sep 17;19(9):2787. doi: 10.3390/ijms19092787.
3
Current state of the art and future of myectomy.心肌切除术的当前技术水平与未来发展
肥厚性梗阻性心肌病患者主动脉的结构与功能特征
Circ Heart Fail. 2025 Feb;18(2):e012384. doi: 10.1161/CIRCHEARTFAILURE.124.012384. Epub 2025 Jan 23.
4
Structure and function of the aortic and pulmonary outflows in a patient, 12 years after Nikaidoh operation, A cautionary Note.尼凯多手术12年后一名患者的主动脉和肺流出道的结构与功能:一则警示
Int J Cardiol Congenit Heart Dis. 2023 Mar 21;12:100450. doi: 10.1016/j.ijcchd.2023.100450. eCollection 2023 Jun.
5
FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancer.FBLN2 在小鼠乳腺上皮细胞中与基底细胞标志物 Krt14 和 ITGB1 相关联,并且在人类乳腺癌的分子亚型中具有优先表达。
Breast Cancer Res Treat. 2024 Dec;208(3):673-686. doi: 10.1007/s10549-024-07447-y. Epub 2024 Aug 7.
6
Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.机器学习驱动的诊断特征为肥厚型心肌病的临床管理提供了新的见解。
ESC Heart Fail. 2024 Aug;11(4):2234-2248. doi: 10.1002/ehf2.14762. Epub 2024 Apr 17.
7
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts.肥厚型心肌病中的心肌纤维化:成纤维细胞的视角。
Int J Mol Sci. 2023 Oct 2;24(19):14845. doi: 10.3390/ijms241914845.
Ann Cardiothorac Surg. 2017 Jul;6(4):307-317. doi: 10.21037/acs.2017.06.04.
4
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.肥厚型心肌病:遗传学、发病机制、临床表现、诊断与治疗
Circ Res. 2017 Sep 15;121(7):749-770. doi: 10.1161/CIRCRESAHA.117.311059.
5
Redefining the identity of cardiac fibroblasts.重新定义心肌成纤维细胞的身份。
Nat Rev Cardiol. 2017 Aug;14(8):484-491. doi: 10.1038/nrcardio.2017.57. Epub 2017 Apr 24.
6
RNA‑seq profiling of mRNA associated with hypertrophic cardiomyopathy.与肥厚型心肌病相关的mRNA的RNA测序分析
Mol Med Rep. 2016 Dec;14(6):5573-5586. doi: 10.3892/mmr.2016.5931. Epub 2016 Nov 8.
7
Defining the Cardiac Fibroblast.定义心脏成纤维细胞。
Circ J. 2016 Oct 25;80(11):2269-2276. doi: 10.1253/circj.CJ-16-1003. Epub 2016 Oct 14.
8
Histological and Histometric Characterization of Myocardial Fibrosis in End-Stage Hypertrophic Cardiomyopathy: A Clinical-Pathological Study of 30 Explanted Hearts.终末期肥厚型心肌病心肌纤维化的组织学和组织计量学特征:30例心脏移植供心的临床病理研究
Circ Heart Fail. 2016 Sep;9(9). doi: 10.1161/CIRCHEARTFAILURE.116.003090.
9
Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.纤连蛋白-2对于由转化生长因子(TGF)-β介导的血管紧张素II诱导的心肌纤维化至关重要。
Lab Invest. 2016 Jul;96(7):773-83. doi: 10.1038/labinvest.2016.52. Epub 2016 Apr 25.
10
Cardiac Fibrosis: The Fibroblast Awakens.心脏纤维化:成纤维细胞觉醒
Circ Res. 2016 Mar 18;118(6):1021-40. doi: 10.1161/CIRCRESAHA.115.306565.